Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32-2 - Emmaus Life Sciences, Inc. | s104819_ex32-2.htm |
| EX-32.1 - EXHIBIT 32-1 - Emmaus Life Sciences, Inc. | s104819_ex32-1.htm |
| EX-31.2 - EXHIBIT 31-2 - Emmaus Life Sciences, Inc. | s104819_ex31-2.htm |
| EX-31.1 - EXHIBIT 31-1 - Emmaus Life Sciences, Inc. | s104819_ex31-1.htm |
| EX-23.1 - EXHIBIT 23-1 - Emmaus Life Sciences, Inc. | s104819_ex23-1.htm |
| EX-10.24 - EXHIBIT 10-24 - Emmaus Life Sciences, Inc. | s104819_ex10-24.htm |
| EX-10.23 - EXHIBIT 10-23 - Emmaus Life Sciences, Inc. | s104819_ex10-23.htm |
| EX-4.6 - EXHIBIT 4-6 - Emmaus Life Sciences, Inc. | s104819_ex4-6.htm |
| EX-4.5 - EXHIBIT 4-5 - Emmaus Life Sciences, Inc. | s104819_ex4-5.htm |
| EX-4.4 - EXHIBIT 4-4 - Emmaus Life Sciences, Inc. | s104819_ex4-4.htm |
| EX-3.1 - EXHIBIT 3-1 - Emmaus Life Sciences, Inc. | s104819_ex3-1.htm |
| 10-K - 10-K - Emmaus Life Sciences, Inc. | s104819_10k.htm |
Exhibit 21.1
CNS Response, Inc., a California corporation and Colorado CNS Response, Inc., a Colorado corporation, are wholly-owned subsidiaries of MYnd Analytics, Inc., a Delaware corporation.
Neuro-Therapy Clinic, Inc., a Colorado corporation, is a wholly-owned subsidiary of Colorado CNS Response, Inc.